You are here

Innovative medicines initiative (IMI): the power of public private partnerships in diabetes research

Friday, 25 September 2020, 12:15 - 13:45, Linz Hall

Chair: S.E. Kahn, US

E.R. Pearson, UK: IMI DIRECT

B. Thorens, CH: IMI RHAPSODY

C. Mathieu, BE: IMI INNODIA

M.F. Gomez, SE: IMI BEAt-DKD

A. Vella, US: Commentary